RxDoctor Payments Data

Avijit Sharma, MD

Pain Medicine · Scottsdale, AZNPI 1245692979

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Abbott at 33.7% of the total. Reporting peaked in 2024 at $9,785 and has fallen 79.0% since, to $2,050 in 2025.

$22,511in general payments, 2019–2025

Across 273 payments — averaging $82.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Boston Scientific$4K
  • Nevro Corp.$3K
  • Saluda Medical Americas, Inc.$2K
  • Relievant Medsystems, Inc.$1K
  • Nalu Medical, Inc.$1K
  • plus $3K from 20 others

What the payments were for

  • Travel & lodging$9,31341%
  • Food & beverage$13,19759%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,511 in reported general payments places this provider in the 85th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$567,472
Medicare patients
1,195
Services billed
17,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen93$2,593
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen106$2,243
Gabapentin93$1,486
Oxycodone Hcl56$1,029
Tramadol Hcl77$453
Pregabalin29$378
Methocarbamol18$374
Methylprednisolone38$257
Tizanidine Hcl30$205
Meloxicam64$198
Cyclobenzaprine Hcl19$161
Morphine Sulfate ErMorphine Sulfate12$150
Celecoxib11$104
Cephalexin17$63

Paid to pharmacies, not to this prescriber.

Other pain medicine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →